ATE530913T1 - Verwendung eines synthetischen peptids aus dem zebra-protein für die in-vitro diagnose von eppstein-barr-virus (ebv)-reaktivierung - Google Patents
Verwendung eines synthetischen peptids aus dem zebra-protein für die in-vitro diagnose von eppstein-barr-virus (ebv)-reaktivierungInfo
- Publication number
- ATE530913T1 ATE530913T1 AT09719883T AT09719883T ATE530913T1 AT E530913 T1 ATE530913 T1 AT E530913T1 AT 09719883 T AT09719883 T AT 09719883T AT 09719883 T AT09719883 T AT 09719883T AT E530913 T1 ATE530913 T1 AT E530913T1
- Authority
- AT
- Austria
- Prior art keywords
- ebv
- reactivation
- eppstein
- synthetic peptide
- barr virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
- G01N2333/05—Epstein-Barr virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08290224A EP2101177A1 (de) | 2008-03-10 | 2008-03-10 | Verwendung eines synthetischen Peptids aus dem ZEBRA-Protein für die in-vitro-Diagnose von Epstein-Barr-Virus (EBV)-Reaktivierung |
PCT/EP2009/052798 WO2009112497A1 (en) | 2008-03-10 | 2009-03-10 | Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE530913T1 true ATE530913T1 (de) | 2011-11-15 |
Family
ID=39595705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09719883T ATE530913T1 (de) | 2008-03-10 | 2009-03-10 | Verwendung eines synthetischen peptids aus dem zebra-protein für die in-vitro diagnose von eppstein-barr-virus (ebv)-reaktivierung |
Country Status (9)
Country | Link |
---|---|
US (1) | US20110076671A1 (de) |
EP (2) | EP2101177A1 (de) |
JP (1) | JP5592277B2 (de) |
CN (1) | CN102016586B (de) |
AT (1) | ATE530913T1 (de) |
CA (1) | CA2718245C (de) |
ES (1) | ES2375095T3 (de) |
MY (1) | MY156432A (de) |
WO (1) | WO2009112497A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2983482B1 (fr) * | 2011-12-05 | 2017-10-20 | Univ Joseph Fourier | Utilisation d'au moins un biomarqueur pour le pronostic ou le diagnostic in vitro d'episodes lymphoproliferatifs associes au virus d'epstein-barr (ebv) |
WO2014025254A1 (en) | 2012-08-10 | 2014-02-13 | Stichting Vu-Vumc | Ebv markers and systemic lupus erythematosus |
CN109679975B (zh) * | 2019-01-23 | 2020-12-08 | 济宁医学院 | 一种改造bzlf1和改造lmp1的融合基因及其应用 |
CN111826412A (zh) * | 2020-06-02 | 2020-10-27 | 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) | 一种高通量检测eb病毒感染效率/抗体阻断eb病毒感染效率的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994006470A1 (en) * | 1992-09-15 | 1994-03-31 | Johnson & Johnson | Immunoreactive peptides from epstein-barr virus |
FR2728904B1 (fr) * | 1995-01-04 | 1997-03-14 | Pasteur Institut | Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif |
ES2170195T3 (es) * | 1995-06-06 | 2002-08-01 | Organon Teknika Bv | Peptidos del virus de epstein-barr y anticuerpos contra estos peptidos. |
JPH11511853A (ja) * | 1996-03-29 | 1999-10-12 | オルソ ダイアグノスティック システムズ インク | エプスタイン・バーウイルス関連疾患の診断法 |
FR2791142B1 (fr) * | 1999-03-17 | 2001-06-22 | Univ Grenoble 1 | Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa |
CA2630218A1 (en) * | 2005-11-18 | 2007-08-30 | The Ohio State University Research Foundation | Viral gene products and methods for vaccination to prevent viral associated diseases |
-
2008
- 2008-03-10 EP EP08290224A patent/EP2101177A1/de not_active Withdrawn
-
2009
- 2009-03-10 JP JP2010550179A patent/JP5592277B2/ja not_active Expired - Fee Related
- 2009-03-10 EP EP09719883A patent/EP2269069B1/de not_active Not-in-force
- 2009-03-10 AT AT09719883T patent/ATE530913T1/de not_active IP Right Cessation
- 2009-03-10 US US12/921,804 patent/US20110076671A1/en not_active Abandoned
- 2009-03-10 MY MYPI2010004281A patent/MY156432A/en unknown
- 2009-03-10 CA CA2718245A patent/CA2718245C/en not_active Expired - Fee Related
- 2009-03-10 ES ES09719883T patent/ES2375095T3/es active Active
- 2009-03-10 WO PCT/EP2009/052798 patent/WO2009112497A1/en active Application Filing
- 2009-03-10 CN CN200980115338.9A patent/CN102016586B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2009112497A1 (en) | 2009-09-17 |
CA2718245C (en) | 2017-04-18 |
CN102016586B (zh) | 2015-01-21 |
EP2101177A1 (de) | 2009-09-16 |
JP5592277B2 (ja) | 2014-09-17 |
US20110076671A1 (en) | 2011-03-31 |
EP2269069B1 (de) | 2011-10-26 |
CA2718245A1 (en) | 2009-09-17 |
JP2011513759A (ja) | 2011-04-28 |
CN102016586A (zh) | 2011-04-13 |
MY156432A (en) | 2016-02-26 |
EP2269069A1 (de) | 2011-01-05 |
ES2375095T3 (es) | 2012-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2687469T3 (es) | Marcadores autoanticuerpos para el diagnóstico de traumatismo craneoencefálico | |
ATE530913T1 (de) | Verwendung eines synthetischen peptids aus dem zebra-protein für die in-vitro diagnose von eppstein-barr-virus (ebv)-reaktivierung | |
WO2006127861A3 (en) | Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations | |
ES2569663T3 (es) | Procedimiento de diagnóstico | |
CY1119412T1 (el) | Μεθοδοι για την αξιολογηση μιας ανοσοαποκρισης σε εναν θεραπευτικο παραγοντα | |
IN2012DN01322A (de) | ||
ATE525648T1 (de) | Testelement mit nanofasern | |
UY29504A1 (es) | Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos. | |
CR20120587A (es) | Moléculas de unión al antígeno que fijan egfr, vectores que las codifican y uso de las mismas | |
DE602006014535D1 (de) | Verwendung von nt-proanp und nt-probnp zur diagnose von herzerkrankungen | |
EP1881008A4 (de) | Verfahren zur in-vitro-diagnose von alzheimer-krankheit mit einem monoklonalen antikörper | |
ATE410178T1 (de) | Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration | |
TW200740840A (en) | Diagnostic test kits | |
ATE548049T1 (de) | Verwendung von ides proteinase (von s. pyogenes) zur behandlung von autoimmunkrankheiten und transplantatabstossung | |
AR081696A1 (es) | Anticuerpo para el diagnostico y/o pronostico de cancer | |
ATE553778T1 (de) | Für humanes hepcidin spezifische antikörper | |
MX2009005788A (es) | Peptidos truncados de hormona paratiroidea con una conformacion ciclica. | |
ATE509096T1 (de) | Von sparc abgeleitetes krebsabstossungsantigenpeptid und pharmazeutikum, das dieses enthält | |
MX2009001937A (es) | Biomarcadores para el progreso de la enfermedad de alzheimer. | |
CY1114618T1 (el) | Βιολογικα δραστικα πεπτιδια που περιεχουν καρβοξυτελικη αργινινη | |
ATE433115T1 (de) | Timp-2 als ziel/marker des versagens von beta- zellen | |
Zbären et al. | A novel functional mast cell assay for the detection of allergies | |
CL2023001600A1 (es) | Biomarcadores del agonista de trem2 y métodos para su uso | |
DE602007006671D1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
de Araújo et al. | Characterization of the presence of Foxp3 (+) T cells from patients with different clinical forms of Chagas' disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |